Status:
COMPLETED
Macular Degeneration and Aging Study
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
Dartmouth-Hitchcock Medical Center
Association for the Blind and Visually Impaired
Conditions:
Age-related Macular Degeneration
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The purpose of this randomized trial is to examine the effectiveness of a psycho-social "Preventive Problem Solving Intervention" on emotional well-being, change in future outlook, and vision function...
Detailed Description
Loss of independence and valued activities places Age-related Macular Degeneration (AMD) patients at increased risk for depression, anxiety, and disability. Patients' emotional and behavioral response...
Eligibility Criteria
Inclusion
- Diagnosis of AMD
- 60 years and older
- Able to communicate in English.
Exclusion
- Significant cognitive impairment at baseline (total score on Mini Mental State Exam (MMSE) for the Blind \<18, equivalent to \<21 in the regular MMSE);
- Residence in a nursing home (assisted living facilities are acceptable);
- Patient is acutely suicidal or psychotic
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT02224963
Start Date
May 1 2009
End Date
April 1 2019
Last Update
April 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester
Rochester, New York, United States, 14642